| Charlene M Anderson, CRNA | |
|
400 N 17th St, Allentown, PA 18104-5052 | |
| (610) 402-9099 | |
| (610) 402-9029 |
| Full Name | Charlene M Anderson |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 36 Years |
| Location | 400 N 17th St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730176629 | NPI | - | NPPES |
| 0063046 | Other | PA | FIRST PRIORITY |
| 0063046 | Other | PA | HIGHMARK |
| 0063046 | Other | PA | KHP CENTRAL |
| 9699193 | Other | PA | AETNA |
| 0070312970003 | Medicaid | PA | |
| 01484202 | Other | PA | CAPITAL ADVANTAGE |
| 0718259000 | Other | PA | INDEP. BLUE CROSS |
| 11766001 | Other | PA | CAQH |
| 1585085 | Other | PA | GATEWAY |
| 82832 | Other | PA | GEISINGER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN266339L (Pennsylvania) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 040491 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
| Lehigh Valley Anesthesia Services, P. C. | 8820992183 | 132 |
News Archive
"Young or old, family planning should be a simple and personal decision made by informed individuals or couples regarding how often and when to have children," Anne Alan Sizomu, the advocacy officer for Deutsche Stiftung Weltbevoelkerung's (DSW) Uganda country office, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26.
Advances in the treatment of children and adolescents with cancer have led to substantial improvements in survival, with a 5-year survival rate of childhood cancer close to 80%.
Researchers are pursuing an innovative and unexpected new avenue in the quest to fight antibiotic resistance: synthetic mucus. By studying and replicating mucus' natural ability to control pathogenic bacteria, the scientists hope to find new methods for combating infections.
Medical professionals all want to be able to quickly and correctly diagnose diseases. Their future ability to do so will depend on identifying what biochemicals are present in tissue sections, where the biomolecules are, and at what concentrations.
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, today announces the completion of patient enrollment of the phase II study of its lead therapeutic vaccine candidate, ProCervix.
› Verified 8 days ago
| Entity Name | Lehigh Valley Anesthesia Services, P. C. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730174731 PECOS PAC ID: 8820992183 Enrollment ID: O20031120000076 |
News Archive
"Young or old, family planning should be a simple and personal decision made by informed individuals or couples regarding how often and when to have children," Anne Alan Sizomu, the advocacy officer for Deutsche Stiftung Weltbevoelkerung's (DSW) Uganda country office, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26.
Advances in the treatment of children and adolescents with cancer have led to substantial improvements in survival, with a 5-year survival rate of childhood cancer close to 80%.
Researchers are pursuing an innovative and unexpected new avenue in the quest to fight antibiotic resistance: synthetic mucus. By studying and replicating mucus' natural ability to control pathogenic bacteria, the scientists hope to find new methods for combating infections.
Medical professionals all want to be able to quickly and correctly diagnose diseases. Their future ability to do so will depend on identifying what biochemicals are present in tissue sections, where the biomolecules are, and at what concentrations.
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, today announces the completion of patient enrollment of the phase II study of its lead therapeutic vaccine candidate, ProCervix.
› Verified 8 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
"Young or old, family planning should be a simple and personal decision made by informed individuals or couples regarding how often and when to have children," Anne Alan Sizomu, the advocacy officer for Deutsche Stiftung Weltbevoelkerung's (DSW) Uganda country office, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26.
Advances in the treatment of children and adolescents with cancer have led to substantial improvements in survival, with a 5-year survival rate of childhood cancer close to 80%.
Researchers are pursuing an innovative and unexpected new avenue in the quest to fight antibiotic resistance: synthetic mucus. By studying and replicating mucus' natural ability to control pathogenic bacteria, the scientists hope to find new methods for combating infections.
Medical professionals all want to be able to quickly and correctly diagnose diseases. Their future ability to do so will depend on identifying what biochemicals are present in tissue sections, where the biomolecules are, and at what concentrations.
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, today announces the completion of patient enrollment of the phase II study of its lead therapeutic vaccine candidate, ProCervix.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charlene M Anderson, CRNA 24 S 18th Street, Allentown, PA 18104-5622 Ph: (610) 628-8372 | Charlene M Anderson, CRNA 400 N 17th St, Allentown, PA 18104-5052 Ph: (610) 402-9099 |
News Archive
"Young or old, family planning should be a simple and personal decision made by informed individuals or couples regarding how often and when to have children," Anne Alan Sizomu, the advocacy officer for Deutsche Stiftung Weltbevoelkerung's (DSW) Uganda country office, writes in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26.
Advances in the treatment of children and adolescents with cancer have led to substantial improvements in survival, with a 5-year survival rate of childhood cancer close to 80%.
Researchers are pursuing an innovative and unexpected new avenue in the quest to fight antibiotic resistance: synthetic mucus. By studying and replicating mucus' natural ability to control pathogenic bacteria, the scientists hope to find new methods for combating infections.
Medical professionals all want to be able to quickly and correctly diagnose diseases. Their future ability to do so will depend on identifying what biochemicals are present in tissue sections, where the biomolecules are, and at what concentrations.
Genticel, a French biotechnology company and leading developer of therapeutic vaccines, today announces the completion of patient enrollment of the phase II study of its lead therapeutic vaccine candidate, ProCervix.
› Verified 8 days ago
Andrew Hornick, DNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1736 Hamilton St, Allentown, PA 18104 Phone: 610-628-8300 | |
Marissa Romo, SRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 100 College Dr, Allentown, PA 18104 Phone: 610-437-4471 | |
Mark T. Peleschak, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5000 Tilghman St, Ste 240, Allentown, PA 18104 Phone: 610-395-4044 Fax: 610-395-5693 | |
Ronald S Horvat, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 24 S 18th St, Allentown, PA 18104 Phone: 610-628-8372 Fax: 610-628-8648 | |
Susan Elizabeth Abrams, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3147 College Heights Blvd, College Heights Endoscopy Center, Allentown, PA 18104 Phone: 610-841-2432 Fax: 610-841-4433 | |
Krisztina Fazio, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Lisa Verbosh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1245 S Cedar Crest Blvd Ste 301, Allentown, PA 18103 Phone: 610-402-8896 Fax: 610-402-9029 |